Esophageal Cancer Molecular Diagnostics Market Analysis

Type (Genetic Tests, Biomarker Detection)

Genetic tests segment is anticipated to capture around 55% esophageal cancer molecular diagnostics market share by the end of 2036. Revolutionary developments in genetic tests are driving a sweeping change in the methods and speed of oesophageal cancer diagnosis. With the rising use of precision medicine and more and more genetic markers underway, there is a scope for high revenue in cancer diagnostics. Identification of the critical genes can help doctors gauge the risk of the incidence of cancer and thereby recommend regular tests. In many cases, the gene is inherited, which can later appear with symptoms, aggressively.

It has been observed that the oesophageal cancer gene is acquired in more instances than inherited. Biomarkers are essential to stitch a targeted treatment to make a full recovery. Organized into two main types, genetic biomarkers, and non-invasive biomarkers, they help chart out a plan to target and squash the cancerous cells. Unfortunately, oesophageal cancers have a mortality rate of 85% if diagnosed in the later stages. These biomarkers prove to be a tipping point in recuperation from the disease.

Application (Disease Diagnosis, Drug Screening)

Disease diagnosis segment in the esophageal cancer molecular diagnostics market is set to exhibit around 6% CAGR till 2036. There’s not one but multiple diagnosing tools to confirm the presence of cancerous cells. It’s essential to determine the extent and the severity of the disease to adequately start the treatment, and curtail the mortality rate. With various diagnosing methods like Barium swallow, collecting sample tissue and endoscopy to confirm the malignancy, and CT, PET, Bronchoscopy, etc, to discern the magnitude of the problem, the market has a high revenue potential.

Advancements in medical technology have made it simpler to avail the diagnostic results in less time. The causative factors for the oesophageal cancer are always on the rise. Hence, people need to rely on these diagnostics to defend their well-being.

Our in-depth analysis of the market includes the following segments: